309 related articles for article (PubMed ID: 11073835)
1. Genetic modifiers of atherosclerosis in mice.
Knowles JW; Maeda N
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2336-45. PubMed ID: 11073835
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.
Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.
Carmeliet P; Collen D
Curr Opin Lipidol; 1997 Apr; 8(2):118-25. PubMed ID: 9183550
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Wang YX
Neurobiol Aging; 2005 Mar; 26(3):309-16. PubMed ID: 15639308
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms of atherosclerosis with mouse models.
Ohashi R; Mu H; Yao Q; Chen C
Trends Cardiovasc Med; 2004 Jul; 14(5):187-90. PubMed ID: 15261890
[TBL] [Abstract][Full Text] [Related]
6. Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4.
Seidelmann SB; De Luca C; Leibel RL; Breslow JL; Tall AR; Welch CL
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):204-10. PubMed ID: 15514201
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
8. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.
Wouters K; Shiri-Sverdlov R; van Gorp PJ; van Bilsen M; Hofker MH
Clin Chem Lab Med; 2005; 43(5):470-9. PubMed ID: 15899668
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of atherosclerosis.
Hegele RA
Int J Clin Lab Res; 1997; 27(1):2-13. PubMed ID: 9144022
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM; Withycombe S; Young SG
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
[TBL] [Abstract][Full Text] [Related]
13. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of the plasminogen and coagulation system in mice.
Carmeliet P; Collen D
Haemostasis; 1996 Oct; 26 Suppl 4():132-53. PubMed ID: 8979118
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis.
Hofker MH; van Vlijmen BJ; Havekes LM
Atherosclerosis; 1998 Mar; 137(1):1-11. PubMed ID: 9568731
[TBL] [Abstract][Full Text] [Related]
16. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
[TBL] [Abstract][Full Text] [Related]
17. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
[TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into the development of atherosclerosis in hemophilia A mouse models.
Fabri DR; de Paula EV; Costa DS; Annichino-Bizzacchi JM; Arruda VR
J Thromb Haemost; 2011 Aug; 9(8):1556-61. PubMed ID: 21692978
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
Meir KS; Leitersdorf E
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1006-14. PubMed ID: 15087308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
